Skip to main content

Table 1 The clinical and demographic characteristics of all the subjects

From: Lipid metabolism contribute to the pathogenesis of IgA Vasculitis

Characteristics of different groups

IgAVs

HCs

IgAV-N

IgAV-C

IgAV0

IgAV1

p value

IgAVs vs HCs

IgAV-N vs IgAV-C

IgAV0 vs IgAV1

Patients (n)

58

28

13

28

15

30

NA

NA

NA

Male (n, %) a

28 (48.3%)

14 (50.0%)

7 (50.0%)

16 (53.6%)

7 (46.7%)

16 (53.3%)

0.881

0.82

0.881

Age (years)

 

2~14

3~17

4~14

7~14

2~14

4~14

NA

NA

NA

 Mean ± SD b

9.17 ± 3.08

10.61 ± 3.67

10.23 ± 2.52

8.50 ± 2.90

8.27 ± 3.67

9.80 ± 2.76

0.061

0.072

0.12

BMI (kg/m2)

 Mean ± SD b

16.47 ± 2.85

18.57 ± 4.51

17.14 ± 1.32

15.88 ± 1.73

15.96 ± 2.10

16.83 ± 3.46

0.01

0.153

0.38

Symptoms

 Purpura

28 (48.28%)

0(0.00%)

2(15.38%)

14(50.00%)

15(100.00%)

14(46.67%)

NA

NA

NA

 Arthralgia

12 (20.69%)

0(0.00%)

1(7.69%)

6(21.43%)

6(40.00%)

6(20.00%)

NA

NA

NA

 Abdominal pain

12 (20.69)

0(0.00%)

0(0.00%)

8(28.57%)

6(40.00%)

6(20.00%)

NA

NA

NA

 Renal biopsy

13 (22.41%)

0(0.00%)

13(100.00%)

0(0.00%)

1(6.67%)

14(46.67%)

NA

NA

NA

 Haematuria

21 (36.21%)

0(0.00%)

2(15.38%)

0(0.00%)

2(13.33%)

6(20.00%)

NA

NA

NA

 Proteinuria

13 (22.41%)

0(0.00%)

8(61.84%)

0(0.00%)

2(13.33%)

13(43.33%)

NA

NA

NA

  1. aAnalyzed by the Chi-square test
  2. bAnalyzed by the ANOVA followed by post hoc comparison of the groups using the Bonferroni test
  3. NA means it cannot be calculated